ECO-RX AIR PURIFIER WITH UV LIGHT, MODEL RX-400

K062716 · Eco-Rx, Inc. · FRA · Oct 27, 2006 · General Hospital

Device Facts

• Record ID: K062716
• Device Name: ECO-RX AIR PURIFIER WITH UV LIGHT, MODEL RX-400
• Applicant: Eco-Rx, Inc.
• Product Code: FRA · General Hospital
• Decision Date: Oct 27, 2006
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 880.6500
• Device Class: Class 2
• Attributes: Therapeutic, 3rd-Party Reviewed

Indications for Use

The ECO-Rx Air Purifier with UV Light, Model Rx-400 is a flow-through indoor air-purification system for the inactivation of indoor airborne bacteria.

Device Story

The ECO-Rx Air Purifier (Model Rx-400) is a flow-through indoor air-purification system designed to reduce airborne bacteria. The device utilizes ultraviolet (UV) light technology to treat air as it passes through the system. It is intended for use in indoor environments to improve air quality by inactivating airborne microorganisms. The device is operated by the user in a general indoor setting. It functions as a standalone air treatment system.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Flow-through air purification system utilizing ultraviolet (UV) light for microbial inactivation. Classified as a medical ultraviolet air purifier (21 CFR 880.6500, Product Code FRA).

Indications for Use

Indicated for the inactivation of indoor airborne bacteria in indoor environments. For over-the-counter use.

Regulatory Classification

Identification

A medical ultraviolet air purifier is a device intended for medical purposes that is used to destroy bacteria in the air by exposure to ultraviolet radiation.

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS). The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an abstract image of an eagle.

## Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

## 0C1 2 7 2006

ECO-Rx, Incorporated C/O Mr. Daniel W. Lehtonen Responsible Third Party Official Intertek Testing Services 2307 East Aurora Road, Unit B7 Twinsburg, Ohio 44087

Re: K062716

Trade/Device Name: ECO-Rx Air Purifier with UV Light Model Rx-400/ Eco-Rx Three-Lamp Ultra-Violet Air Treatment System Regulation Number: 21 CFR 880.6500 Regulation Name: Medical Ultraviolet Air Purifier Regulatory Class: II Product Code: FRA Dated: October 18, 2006 Received: October 19, 2006

Dear Mr. Lehtonen:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Page 2 - Mr. Lehtonen

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Susan Dunno

Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

## Indications for Use

510(k) Number (if known):

Not Assigned Yet KOG 271 6

Device Name:

ECO-Rx Air Purifier with UV Light Model Rx-400/ Eco-Rx Three-Lamp Ultra-Violet Air Treatment System

Indications For Use:

The ECO-Rx Air Purifier with UV Light, Model Rx-400 is a flow-through indoor air-purification system for the inactivation of indoor airborne bacteria.

Prescription Use (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use × (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Shule T. Murphy, MD 10/27/06

I of Anasthesiology, General Hospit on Control, Dental Devices

K06274

Page 1 of **__**